HR 2506 RFS

September 30, 1999

Received; read twice and referred to the Committee on Health, Education, Labor, and Pensions

To amend title IX of the Public Health Service Act to revise and extend the Agency for Health Care Policy and Research.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the `Health Research and Quality Act of 1999'.

SEC. 2. AMENDMENT TO THE PUBLIC HEALTH SERVICE ACT.

(a) IN GENERAL- Title IX of the Public Health Service Act (42 U.S.C. 299 et seq.) is amended to read as follows:

`TITLE IX--AGENCY FOR HEALTH RESEARCH AND QUALITY

`PART A--ESTABLISHMENT AND GENERAL DUTIES

`SEC. 901. MISSION AND DUTIES.

`(a) IN GENERAL- There is established within the Public Health Service an agency to be known as the Agency for Health Research and Quality, which shall be headed by a director appointed by the Secretary. The Secretary shall carry out this title acting through the Director.

`(b) MISSION- The purpose of the Agency is to enhance the quality, appropriateness, and effectiveness of health services, and access to such services, through the establishment of a broad base of scientific research and through the promotion of improvements in clinical and health system practices, including the prevention of diseases and other health conditions. The Agency shall promote health care quality improvement by conducting and supporting--

`(1) research that develops and presents scientific evidence regarding all aspects of health, including--

`(A) the development and assessment of methods for enhancing patient participation in their own care and for facilitating shared patient-physician decision-making;

`(B) the outcomes, effectiveness, and cost-effectiveness of health care practices, including preventive measures and long-term care;

`(C) existing and innovative technologies;

`(D) the costs and utilization of, and access to health care;

`(E) the ways in which health care services are organized, delivered, and financed and the interaction and impact of these factors on the quality of patient care;

`(F) methods for measuring quality and strategies for improving quality; and

`(G) ways in which patients, consumers, purchasers, and practitioners acquire new information about best practices and health benefits, the determinants and impact of their use of this information;

`(2) the synthesis and dissemination of available scientific evidence for use by patients, consumers, practitioners, providers, purchasers, policy makers, and educators; and

`(3) initiatives to advance private and public efforts to improve health care quality.

`(c) REQUIREMENTS WITH RESPECT TO SPECIAL POPULATIONS- There is established within the Agency an office to be known as the Office on Special Populations, which shall be headed by an official appointed by the Director. The Director, acting through such Office, shall conduct and support research and evaluations, and support demonstration projects, with respect to--

`(1) the delivery of health services in inner-city areas and in rural areas (including frontier areas);

`(2) health services for low-income groups, and minority groups;

`(3) the health of children;

`(4) the elderly; and

`(5) people with special health care needs, including disabilities, chronic care and end-of-life health care.

`SEC. 902. GENERAL AUTHORITIES.

`(a) IN GENERAL- In carrying out section 901(b), the Director shall conduct and support research, evaluations, and training, support demonstration projects, research networks, and multi-disciplinary centers, provide technical assistance, and disseminate information on health care and on systems for the delivery of such care, including activities with respect to--

`(1) the quality, effectiveness, efficiency, appropriateness and value of health care services;

`(2) quality measurement and improvement;

`(3) the outcomes, cost, cost-effectiveness, and use of health care services and access to such services;

`(4) clinical practice, including primary care and practice-oriented research;

`(5) health care technologies, facilities, and equipment;

`(6) health care costs, productivity, organization, and market forces;

`(7) health promotion and disease prevention, including clinical preventive services;

`(8) health statistics, surveys, database development, and epidemiology; and

`(9) medical liability.

`(b) HEALTH SERVICES TRAINING GRANTS-

`(1) IN GENERAL- The Director may provide training grants in the field of health services research related to activities authorized under subsection (a), to include pre- and post-doctoral fellowships and training programs, young investigator awards, and other programs and activities as appropriate. In carrying out this subsection, the Director shall make use of funds made available under section 487(d)(3) for the Agency.

`(2) REQUIREMENTS- In developing priorities for the allocation of training funds under this subsection, the Director shall take into consideration shortages in the number of trained researchers who are members of one of the priority populations and the number of trained researchers who are addressing the priority populations.

`(c) MULTIDISCIPLINARY CENTERS- The Director may provide financial assistance to assist in meeting the costs of planning and establishing new centers, and operating existing and new centers, for multidisciplinary health services research, demonstration projects, evaluations, training, and policy analysis with respect to the matters referred to in subsection (a).

`(d) RELATION TO CERTAIN AUTHORITIES REGARDING SOCIAL SECURITY- Activities authorized in this section shall be appropriately coordinated with experiments, demonstration projects, and other related activities authorized by the Social Security Act and the Social Security Amendments of 1967. Activities under subsection (a)(2) of this section that affect the programs under titles XVIII, XIX and XXI of the Social Security Act shall be carried out consistent with section 1142 of such Act.

`(e) DISCLAIMER- The Agency shall not mandate national standards of clinical practice or quality health care standards. Recommendations resulting from projects funded and published by the Agency shall include a corresponding disclaimer.

`(f) RULE OF CONSTRUCTION- Nothing in this section shall be construed to imply that the Agency's role is to mandate a national standard or specific approach to quality measurement and reporting. In research and quality improvement activities, the Agency shall consider a wide range of choices, providers, health care delivery systems, and individual preferences.

`(g) ANNUAL REPORT- Beginning with fiscal year 2003, the Director shall annually submit to the Congress a report regarding prevailing disparities in health care delivery as it relates to racial factors and socioeconomic factors in priority populations.

`PART B--HEALTH CARE IMPROVEMENT RESEARCH

`SEC. 911. HEALTH CARE OUTCOME IMPROVEMENT RESEARCH.

`(a) EVIDENCE RATING SYSTEMS- In collaboration with experts from the public and private sector, the Agency shall identify and disseminate methods or systems to assess health care research results, particularly methods or systems to rate the strength of the scientific evidence underlying health care practice, recommendations in the research literature, and technology assessments. The Agency shall make methods or systems for evidence rating widely available. Agency publications containing health care recommendations shall indicate the level of substantiating evidence using such methods or systems.

`(b) HEALTH CARE IMPROVEMENT RESEARCH CENTERS AND PROVIDER-BASED RESEARCH NETWORKS-

`(1) IN GENERAL- In order to address the full continuum of care and outcomes research, to link research to practice improvement, and to speed the dissemination of research findings to community practice settings, the Agency shall employ research strategies and mechanisms that will link research directly with clinical practice in geographically diverse locations throughout the United States, including--

`(A) health care improvement research centers that combine demonstrated multidisciplinary expertise in outcomes or quality improvement research with linkages to relevant sites of care;

`(B) provider-based research networks, including plan, facility, or delivery system sites of care (especially primary care), that can evaluate outcomes and evaluate and promote quality improvement; and

`(C) other innovative mechanisms or strategies to link research with clinical practice.

`(2) REQUIREMENTS- The Director is authorized to establish the requirements for entities applying for grants under this subsection.

`SEC. 912. PRIVATE-PUBLIC PARTNERSHIPS TO IMPROVE ORGANIZATION AND DELIVERY.

`(a) SUPPORT FOR EFFORTS TO DEVELOP INFORMATION ON QUALITY-

`(1) SCIENTIFIC AND TECHNICAL SUPPORT- In its role as the principal agency for health research and quality, the Agency may provide scientific and technical support for private and public efforts to improve health care quality, including the activities of accrediting organizations.

`(2) ROLE OF THE AGENCY- With respect to paragraph (1), the role of the Agency shall include--

`(A) the identification and assessment of methods for the evaluation of the health of--

`(i) enrollees in health plans by type of plan, provider, and provider arrangements; and

`(ii) other populations, including those receiving long-term care services;

`(B) the ongoing development, testing, and dissemination of quality measures, including measures of health and functional outcomes;

`(C) the compilation and dissemination of health care quality measures developed in the private and public sector;

`(D) assistance in the development of improved health care information systems;

`(E) the development of survey tools for the purpose of measuring participant and beneficiary assessments of their health care; and

`(F) identifying and disseminating information on mechanisms for the integration of information on quality into purchaser and consumer decision-making processes.

`(b) CENTERS FOR EDUCATION AND RESEARCH ON THERAPEUTICS-

`(1) IN GENERAL- The Secretary, acting through the Director and in consultation with the Commissioner of Food and Drugs, shall establish a program for the purpose of making one or more grants for the establishment and operation of one or more centers to carry out the activities specified in paragraph (2).

`(2) REQUIRED ACTIVITIES- The activities referred to in this paragraph are the following:

`(A) The conduct of state-of-the-art research for the following purposes:

`(i) To increase awareness of--

`(I) new uses of drugs, biological products, and devices;

`(II) ways to improve the effective use of drugs, biological products, and devices; and

`(III) risks of new uses and risks of combinations of drugs and biological products.

`(ii) To provide objective clinical information to the following individuals and entities:

`(I) Health care practitioners and other providers of health care goods or services.

`(II) Pharmacists, pharmacy benefit managers and purchasers.

`(III) Health maintenance organizations and other managed health care organizations.

`(IV) Health care insurers and governmental agencies.

`(V) Patients and consumers.

`(iii) To improve the quality of health care while reducing the cost of health care through--

`(I) an increase in the appropriate use of drugs, biological products, or devices; and

`(II) the prevention of adverse effects of drugs, biological products, and devices and the consequences of such effects, such as unnecessary hospitalizations.

`(B) The conduct of research on the comparative effectiveness, cost-effectiveness, and safety of drugs, biological products, and devices.

`(C) The conduct of research on methods to reduce the costs to consumers of obtaining prescription drugs.

`(D) Such other activities as the Secretary determines to be appropriate, except that a grant may not be expended to assist the Secretary in the review of new drugs.

`(c) REDUCING ERRORS IN MEDICINE- The Director shall conduct and support research and build private-public partnerships to--

`(1) identify the causes of preventable health care errors and patient injury in health care delivery;

`(2) develop, demonstrate, and evaluate strategies for reducing errors and improving patient safety; and

`(3) promote the implementation of effective strategies throughout the health care industry.

`(d) CANCER AND CARDIOVASCULAR DISEASES IN WOMEN- The Director shall conduct and support research and build private-public partnerships to enhance the quality, appropriateness, and effectiveness of and access to health services regarding cancer and cardiovascular diseases in women, including with respect to the comparative effectiveness, cost-effectiveness, and safety of such services.

`(e) STUDIES OF METHODS TO IMPROVE ACCESS TO HEALTH SERVICES- The Director shall conduct, and shall provide scientific and technical support for private and public efforts to conduct, studies of the organization, delivery, and financing of health services in order to determine the cost and quality effects of various methods of substantially increasing the number of individuals in the United States who have access to health services. Such studies shall include an examination of the financial impacts of a range of health reform proposals to include, but not be limited to, a single payor insurance program compared to the current system across an 8 year period beginning in fiscal year 2000.

`SEC. 913. INFORMATION ON QUALITY AND COST OF CARE.

`(a) IN GENERAL- The Director shall--

`(1) conduct a survey to collect data on a nationally representative sample of the population on the cost, use and, for fiscal year 2001 and subsequent fiscal years, quality of health care, including the types of health care services Americans use, their access to health care services, frequency of use, how much is paid for the services used, the source of those payments, the types and costs of private health insurance, access, satisfaction, and quality of care for the general population and also for populations identified in section 901(c); and

`(2) develop databases and tools that provide information to States on the quality, access, and use of health care services provided to their residents.

`(b) QUALITY AND OUTCOMES INFORMATION-

`(1) IN GENERAL- Beginning in fiscal year 2001, the Director shall ensure that the survey conducted under subsection (a)(1) will--

`(A) identify determinants of health outcomes and functional status, including the health care needs of populations identified in section 901(c), provide data to study the relationships between health care quality, outcomes, access, use, and cost, measure changes over time, and monitor the overall national impact of Federal and State policy changes on health care;

`(B) provide information on the quality of care and patient outcomes for frequently occurring clinical conditions for a nationally representative sample of the population; and

`(C) provide reliable national estimates for children and persons with special health care needs through the use of supplements or periodic expansions of the survey.

In expanding the Medical Expenditure Panel Survey, as in existence on the date of the enactment of this title in fiscal year 2001 to collect information on the quality of care, the Director shall take into account any outcomes measurements generally collected by private sector accreditation organizations.

`(2) ANNUAL REPORT- Beginning in fiscal year 2003, the Secretary, acting through the Director, shall submit to Congress an annual report on national trends in the quality of health care provided to the American people.

`SEC. 914. INFORMATION SYSTEMS FOR HEALTH CARE IMPROVEMENT.

`(a) IN GENERAL- In order to foster a range of innovative approaches to the management and communication of health information, the Agency shall conduct and support research, evaluations, and initiatives to advance--

`(1) the use of information systems for the study of health care quality and outcomes, including the generation of both individual provider and plan-level comparative performance data;

`(2) training for health care practitioners and researchers in the use of information systems;

`(3) the creation of effective linkages between various sources of health information, including the development of information networks;

`(4) the delivery and coordination of evidence-based health care services, including the use of real-time health care decision-support programs;

`(5) the structure, content, definition, and coding of health information data and medical vocabularies in consultation with appropriate Federal entities and shall seek input from appropriate private entities;

`(6) the use of computer-based health records in outpatient and inpatient settings as a personal health record for individual health assessment and maintenance, and for monitoring public health and outcomes of care within populations; and

`(7) the protection of individually identifiable information in health services research and health care quality improvement.

`(b) DEMONSTRATION- The Agency shall support demonstrations into the use of new information tools aimed at improving shared decision-making between patients and their care-givers.

`(c) CERTAIN LINKAGES REGARDING HEALTH INFORMATION- Initiatives under subsection (a) shall include the establishment, through a site maintained by the Director on the telecommunications medium known as the World Wide Web, of linkages meeting appropriate criteria that enable users of the site to obtain information from consumer satisfaction agencies or other entities that perform evaluations regarding the quality of health care, including more than one link to entities that evaluate health maintenance organizations, and including a link to the National Committee for Quality Assurance.

`SEC. 915. RESEARCH SUPPORTING PRIMARY CARE AND ACCESS IN UNDERSERVED AREAS.

`(a) PREVENTIVE SERVICES TASK FORCE-

`(1) PURPOSE- The Agency shall provide ongoing administrative, research, and technical support for the operation of the Preventive Services Task Force. The Agency shall coordinate and support the dissemination of the Preventive Services Task Force recommendations.

`(2) OPERATION- The Preventive Services Task Force shall review the scientific evidence related to the effectiveness, appropriateness, and cost-effectiveness of clinical preventive services for the purpose of developing recommendations for the health care community, and updating previous recommendations, regarding their usefulness in daily clinical practice. In carrying out its responsibilities under paragraph (1), the Task Force shall not be subject to the provisions of Appendix 2 of title 5, United States Code.

`(b) PRIMARY CARE RESEARCH-

`(1) IN GENERAL- There is established within the Agency a Center for Primary Care Research (referred to in this subsection as the `Center') that shall serve as the principal source of funding for primary care practice research in the Department of Health and Human Services. For purposes of this paragraph, primary care research focuses on the first contact when illness or health concerns arise, the diagnosis, treatment or referral to specialty care, preventive care, and the relationship between the clinician and the patient in the context of the family and community.

`(2) RESEARCH- In carrying out this section, the Center shall conduct and support research concerning--

`(A) the nature and characteristics of primary care practice;

`(B) the management of commonly occurring clinical problems;

`(C) the management of undifferentiated clinical problems; and

`(D) the continuity and coordination of health services.

`SEC. 916. CLINICAL PRACTICE AND TECHNOLOGY INNOVATION.

`(a) IN GENERAL- The Director shall promote innovation in evidence-based health care practices and technologies by--

`(1) conducting and supporting research on the development, diffusion, and use of health care technology;

`(2) developing, evaluating, and disseminating methodologies for assessments of health care practices and technologies;

`(3) conducting intramural and supporting extramural assessments of existing and new health care practices and technologies;

`(4) promoting education and training and providing technical assistance in the use of health care practice and technology assessment methodologies and results; and

`(5) working with the National Library of Medicine and the public and private sector to develop an electronic clearinghouse of currently available assessments and those in progress.

`(b) SPECIFICATION OF PROCESS-

`(1) IN GENERAL- Not later than December 31, 2000, the Director shall develop and publish a description of the methods used by the Agency and its contractors for practice and technology assessment.

`(2) CONSULTATIONS- In carrying out this subsection, the Director shall cooperate and consult with the Assistant Secretary for Health, the Administrator of the Health Care Financing Administration, the Director of the National Institutes of Health, the Commissioner of Food and Drugs, and the heads of any other interested Federal department or agency, and shall seek input, where appropriate, from professional societies and other private and public entities.

`(3) METHODOLOGY- The Director shall, in developing the methods used under paragraph (1), consider--

`(A) safety, efficacy, and effectiveness;

`(B) legal, social, and ethical implications;

`(C) costs, benefits, and cost-effectiveness;

`(D) comparisons to alternate health care technologies and practices; and

`(E) requirements of Food and Drug Administration approval to avoid duplication.

`(c) SPECIFIC ASSESSMENTS-

`(1) IN GENERAL- The Director shall conduct or support specific assessments of health care technologies and practices.

`(2) REQUESTS FOR ASSESSMENTS- The Director is authorized to conduct or support assessments, on a reimbursable basis, for the Health Care Financing Administration, the Department of Defense, the Department of Veterans Affairs, the Office of Personnel Management, and other public or private entities.

`(3) GRANTS AND CONTRACTS- In addition to conducting assessments, the Director may make grants to, or enter into cooperative agreements or contracts with, entities described in paragraph (4) for the purpose of conducting assessments of experimental, emerging, existing, or potentially outmoded health care technologies, and for related activities.

`(4) ELIGIBLE ENTITIES- An entity described in this paragraph is an entity that is determined to be appropriate by the Director, including academic medical centers, research institutions and organizations, professional organizations, third party payers, governmental agencies, minority institutions of higher education (such as Historically Black Colleges and Universities, and Hispanic institutions), and consortia of appropriate research entities established for the purpose of conducting technology assessments.

`(d) MEDICAL EXAMINATION OF CERTAIN VICTIMS-

`(1) IN GENERAL- In carrying out subsection (a), the Director shall promote evidence-based clinical practices for--

`(A) the examination and treatment by health professionals of individuals who are victims of sexual assault (including child molestation) or attempted sexual assault; and

`(B) the training of health professionals on performing medical evidentiary examinations of individuals who are victims of child abuse or neglect, sexual assault, elder abuse, or domestic violence.

`(2) CERTAIN CONSIDERATIONS- Evidence-based clinical practices promoted under paragraph (1) shall take into consideration the expertise and experience of Federal and State law enforcement officials regarding the victims referred to in such paragraph, and of other appropriate public and private entities (including medical societies, victim services organizations, sexual assault prevention organizations, and social services organizations).

`(e) CERTAIN TECHNOLOGIES AND PRACTICES REGARDING SURVIVAL RATES FOR CARDIAC ARREST- In carrying out subsection (a) with respect to innovations in health care technologies and clinical practice, the Director shall, in consultation with appropriate public and private entities, develop recommendations regarding the placement of automatic external defibrillators in Federal buildings as a means of improving the survival rates of individuals who experience cardiac arrest in such buildings, including recommendations on training, maintenance, and medical oversight, and on coordinating with the system for emergency medical services.

`SEC. 917. COORDINATION OF FEDERAL GOVERNMENT QUALITY IMPROVEMENT EFFORTS.

`(a) REQUIREMENT-

`(1) IN GENERAL- To avoid duplication and ensure that Federal resources are used efficiently and effectively, the Secretary, acting through the Director, shall coordinate all research, evaluations, and demonstrations related to health services research, quality measurement and quality improvement activities undertaken and supported by the Federal Government.

`(2) SPECIFIC ACTIVITIES- The Director, in collaboration with the appropriate Federal officials representing all concerned executive agencies and departments, shall develop and manage a process to--

`(A) improve interagency coordination, priority setting, and the use and sharing of research findings and data pertaining to Federal quality improvement programs, technology assessment, and health services research;

`(B) strengthen the research information infrastructure, including databases, pertaining to Federal health services research and health care quality improvement initiatives;

`(C) set specific goals for participating agencies and departments to further health services research and health care quality improvement; and

`(D) strengthen the management of Federal health care quality improvement programs.

`(b) STUDY BY THE INSTITUTE OF MEDICINE-

`(1) IN GENERAL- To provide Congress, the Department of Health and Human Services, and other relevant departments with an independent, external review of their quality oversight, quality improvement and quality research programs, the Secretary shall enter into a contract with the Institute of Medicine--

`(A) to describe and evaluate current quality improvement, quality research and quality monitoring processes through--

`(i) an overview of pertinent health services research activities and quality improvement efforts conducted by all Federal programs, with particular attention paid to those under titles XVIII, XIX, and XXI of the Social Security Act; and

`(ii) a summary of the partnerships that the Department of Health and Human Services has pursued with private accreditation, quality measurement and improvement organizations; and

`(B) to identify options and make recommendations to improve the efficiency and effectiveness of quality improvement programs through--

`(i) the improved coordination of activities across the medicare, medicaid and child health insurance programs under titles XVIII, XIX and XXI of the Social Security Act and health services research programs;

`(ii) the strengthening of patient choice and participation by incorporating state-of-the-art quality monitoring tools and making information on quality available; and

`(iii) the enhancement of the most effective programs, consolidation as appropriate, and elimination of duplicative activities within various federal agencies.

`(2) REQUIREMENTS-

`(A) IN GENERAL- The Secretary shall enter into a contract with the Institute of Medicine for the preparation--

`(i) not later than 12 months after the date of the enactment of this title, of a report providing an overview of the quality improvement programs of the Department of Health and Human Services for the medicare, medicaid, and CHIP programs under titles XVIII, XIX, and XXI of the Social Security Act; and

`(ii) not later than 24 months after the date of the enactment of this title, of a final report containing recommendations.

`(B) REPORTS- The Secretary shall submit the reports described in subparagraph (A) to the Committee on Finance and the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Ways and Means and the Committee on Commerce of the House of Representatives.

`PART C--GENERAL PROVISIONS

`SEC. 921. ADVISORY COUNCIL FOR HEALTH CARE RESEARCH AND QUALITY.

`(a) ESTABLISHMENT- There is established an advisory council to be known as the National Advisory Council for Health Care Research and Quality.

`(b) DUTIES-

`(1) IN GENERAL- The Advisory Council shall advise the Secretary and the Director with respect to activities proposed or undertaken to carry out the purpose of the Agency under section 901(b).

`(2) CERTAIN RECOMMENDATIONS- Activities of the Advisory Council under paragraph (1) shall include making recommendations to the Director regarding--

`(A) priorities regarding health care research, especially studies related to quality, outcomes, cost and the utilization of, and access to, health care services;

`(B) the field of health care research and related disciplines, especially issues related to training needs, and dissemination of information pertaining to health care quality; and

`(C) the appropriate role of the Agency in each of these areas in light of private sector activity and identification of opportunities for public-private sector partnerships.

`(c) MEMBERSHIP-

`(1) IN GENERAL- The Advisory Council shall, in accordance with this subsection, be composed of appointed members and ex officio members. All members of the Advisory Council shall be voting members other than the individuals designated under paragraph (3)(B) as ex officio members.

`(2) APPOINTED MEMBERS- The Secretary shall appoint to the Advisory Council 18 appropriately qualified individuals. At least 14 members of the Advisory Council shall be representatives of the public who are not officers or employees of the United States. The Secretary shall ensure that the appointed members of the Council, as a group, are representative of professions and entities concerned with, or affected by, activities under this title and under section 1142 of the Social Security Act. Of such members--

`(A) three shall be individuals distinguished in the conduct of research, demonstration projects, and evaluations with respect to health care;

`(B) three shall be individuals distinguished in the practice of medicine of which at least one shall be a primary care practitioner;

`(C) three shall be individuals distinguished in the other health professions;

`(D) three shall be individuals either representing the private health care sector, including health plans, providers, and purchasers or individuals distinguished as administrators of health care delivery systems;

`(E) three shall be individuals distinguished in the fields of health care quality improvement, economics, information systems, law, ethics, business, or public policy; and

`(F) three shall be individuals representing the interests of patients and consumers of health care.

`(3) EX OFFICIO MEMBERS- The Secretary shall designate as ex officio members of the Advisory Council--

`(A) the Assistant Secretary for Health, the Director of the National Institutes of Health, the Director of the Centers for Disease Control and Prevention, the Administrator of the Health Care Financing Administration, the Assistant Secretary of Defense (Health Affairs), and the Under Secretary for Health of the Department of Veterans Affairs; and

`(B) such other Federal officials as the Secretary may consider appropriate.

`(d) TERMS- Members of the Advisory Council appointed under subsection (c)(2) shall serve for a term of 3 years. A member of the Council appointed under such subsection may continue to serve after the expiration of the term of the members until a successor is appointed.

`(e) VACANCIES- If a member of the Advisory Council appointed under subsection (c)(2) does not serve the full term applicable under subsection (d), the individual appointed to fill the resulting vacancy shall be appointed for the remainder of the term of the predecessor of the individual.

`(f) CHAIR- The Director shall, from among the members of the Advisory Council appointed under subsection (c)(2), designate an individual to serve as the chair of the Advisory Council.

`(g) MEETINGS- The Advisory Council shall meet not less than once during each discrete 4-month period and shall otherwise meet at the call of the Director or the chair.

`(h) COMPENSATION AND REIMBURSEMENT OF EXPENSES-

`(1) APPOINTED MEMBERS- Members of the Advisory Council appointed under subsection (c)(2) shall receive compensation for each day (including travel time) engaged in carrying out the duties of the Advisory Council unless declined by the member. Such compensation may not be in an amount in excess of the daily equivalent of the annual rate of basic pay prescribed for level IV of the Executive Schedule under section 5315 of title 5, United States Code, for each day during which such member is engaged in the performance of the duties of the Advisory Council.

`(2) EX OFFICIO MEMBERS- Officials designated under subsection (c)(3) as ex officio members of the Advisory Council may not receive compensation for service on the Advisory Council in addition to the compensation otherwise received for duties carried out as officers of the United States.

`(i) STAFF- The Director shall provide to the Advisory Council such staff, information, and other assistance as may be necessary to carry out the duties of the Council.

`SEC. 922. PEER REVIEW WITH RESPECT TO GRANTS AND CONTRACTS.

`(a) REQUIREMENT OF REVIEW-

`(1) IN GENERAL- Appropriate technical and scientific peer review shall be conducted with respect to each application for a grant, cooperative agreement, or contract under this title.

`(2) REPORTS TO DIRECTOR- Each peer review group to which an application is submitted pursuant to paragraph (1) shall report its finding and recommendations respecting the application to the Director in such form and in such manner as the Director shall require.

`(b) APPROVAL AS PRECONDITION OF AWARDS- The Director may not approve an application described in subsection (a)(1) unless the application is recommended for approval by a peer review group established under subsection (c).

`(c) ESTABLISHMENT OF PEER REVIEW GROUPS-

`(1) IN GENERAL- The Director shall establish such technical and scientific peer review groups as may be necessary to carry out this section. Such groups shall be established without regard to the provisions of title 5, United States Code, that govern appointments in the competitive service, and without regard to the provisions of chapter 51, and subchapter III of chapter 53, of such title that relate to classification and pay rates under the General Schedule.

`(2) MEMBERSHIP- The members of any peer review group established under this section shall be appointed from among individuals who by virtue of their training or experience are eminently qualified to carry out the duties of such peer review group. Officers and employees of the United States may not constitute more than 25 percent of the membership of any such group. Such officers and employees may not receive compensation for service on such groups in addition to the compensation otherwise received for these duties carried out as such officers and employees.

`(3) DURATION- Notwithstanding section 14(a) of the Federal Advisory Committee Act, peer review groups established under this section may continue in existence until otherwise provided by law.

`(4) QUALIFICATIONS- Members of any peer-review group shall, at a minimum, meet the following requirements:

`(A) Such members shall agree in writing to treat information received, pursuant to their work for the group, as confidential information, except that this subparagraph shall not apply to public records and public information.

`(B) Such members shall agree in writing to recuse themselves from participation in the peer-review of specific applications which present a potential personal conflict of interest or appearance of such conflict, including employment in a directly affected organization, stock ownership, or any financial or other arrangement that might introduce bias in the process of peer-review.

`(d) AUTHORITY FOR PROCEDURAL ADJUSTMENTS IN CERTAIN CASES- In the case of applications for financial assistance whose direct costs will not exceed $100,000, the Director may make appropriate adjustments in the procedures otherwise established by the Director for the conduct of peer review under this section. Such adjustments may be made for the purpose of encouraging the entry of individuals into the field of research, for the purpose of encouraging clinical practice-oriented or provider-based research, and for such other purposes as the Director may determine to be appropriate.

`(e) REGULATIONS- The Director shall issue regulations for the conduct of peer review under this section.

`SEC. 923. CERTAIN PROVISIONS WITH RESPECT TO DEVELOPMENT, COLLECTION, AND DISSEMINATION OF DATA.

`(a) STANDARDS WITH RESPECT TO UTILITY OF DATA-

`(1) IN GENERAL- To ensure the utility, accuracy, and sufficiency of data collected by or for the Agency for the purpose described in section 901(b), the Director shall establish standard methods for developing and collecting such data, taking into consideration--

`(A) other Federal health data collection standards; and

`(B) the differences between types of health care plans, delivery systems, health care providers, and provider arrangements.

`(2) RELATIONSHIP WITH OTHER DEPARTMENT PROGRAMS- In any case where standards under paragraph (1) may affect the administration of other programs carried out by the Department of Health and Human Services, including the programs under title XVIII, XIX or XXI of the Social Security Act, or may affect health information that is subject to a standard developed under part C of title XI of the Social Security Act, they shall be in the form of recommendations to the Secretary for such program.

`(b) STATISTICS AND ANALYSES- The Director shall--

`(1) take appropriate action to ensure that statistics and analyses developed under this title are of high quality, timely, and duly comprehensive, and that the statistics are specific, standardized, and adequately analyzed and indexed; and

`(2) publish, make available, and disseminate such statistics and analyses on as wide a basis as is practicable.

`(c) AUTHORITY REGARDING CERTAIN REQUESTS- Upon request of a public or private entity, the Director may conduct or support research or analyses otherwise authorized by this title pursuant to arrangements under which such entity will pay the cost of the services provided. Amounts received by the Director under such arrangements shall be available to the Director for obligation until expended.

`SEC. 924. DISSEMINATION OF INFORMATION.

`(a) IN GENERAL- The Director shall--

`(1) without regard to section 501 of title 44, United States Code, promptly publish, make available, and otherwise disseminate, in a form understandable and on as broad a basis as practicable so as to maximize its use, the results of research, demonstration projects, and evaluations conducted or supported under this title;

`(2) ensure that information disseminated by the Agency is science-based and objective and undertakes consultation as necessary to assess the appropriateness and usefulness of the presentation of information that is targeted to specific audiences;

`(3) promptly make available to the public data developed in such research, demonstration projects, and evaluations;

`(4) provide, in collaboration with the National Library of Medicine where appropriate, indexing, abstracting, translating, publishing, and other services leading to a more effective and timely dissemination of information on research, demonstration projects, and evaluations with respect to health care to public and private entities and individuals engaged in the improvement of health care delivery and the general public, and undertake programs to develop new or improved methods for making such information available; and

`(5) as appropriate, provide technical assistance to State and local government and health agencies and conduct liaison activities to such agencies to foster dissemination.

`(b) PROHIBITION AGAINST RESTRICTIONS- Except as provided in subsection (c), the Director may not restrict the publication or dissemination of data from, or the results of, projects conducted or supported under this title.

`(c) LIMITATION ON USE OF CERTAIN INFORMATION- No information, if an establishment or person supplying the information or described in it is identifiable, obtained in the course of activities undertaken or supported under this title may be used for any purpose other than the purpose for which it was supplied unless such establishment or person has consented (as determined under regulations of the Director) to its use for such other purpose. Such information may not be published or released in other form if the person who supplied the information or who is described in it is identifiable unless such person has consented (as determined under regulations of the Director) to its publication or release in other form.

`(d) PENALTY- Any person who violates subsection (c) shall be subject to a civil monetary penalty of not more than $10,000 for each such violation involved. Such penalty shall be imposed and collected in the same manner as civil money penalties under subsection (a) of section 1128A of the Social Security Act are imposed and collected.

`SEC. 925. ADDITIONAL PROVISIONS WITH RESPECT TO GRANTS AND CONTRACTS.

`(a) FINANCIAL CONFLICTS OF INTEREST- With respect to projects for which awards of grants, cooperative agreements, or contracts are authorized to be made under this title, the Director shall by regulation define--

`(1) the specific circumstances that constitute financial interests in such projects that will, or may be reasonably expected to, create a bias in favor of obtaining results in the projects that are consistent with such interests; and

`(2) the actions that will be taken by the Director in response to any such interests identified by the Director.

`(b) REQUIREMENT OF APPLICATION- The Director may not, with respect to any program under this title authorizing the provision of grants, cooperative agreements, or contracts, provide any such financial assistance unless an application for the assistance is submitted to the Secretary and the application is in such form, is made in such manner, and contains such agreements, assurances, and information as the Director determines to be necessary to carry out the program involved.

`(c) PROVISION OF SUPPLIES AND SERVICES IN LIEU OF FUNDS-

`(1) IN GENERAL- Upon the request of an entity receiving a grant, cooperative agreement, or contract under this title, the Secretary may, subject to paragraph (2), provide supplies, equipment, and services for the purpose of aiding the entity in carrying out the project involved and, for such purpose, may detail to the entity any officer or employee of the Department of Health and Human Services.

`(2) CORRESPONDING REDUCTION IN FUNDS- With respect to a request described in paragraph (1), the Secretary shall reduce the amount of the financial assistance involved by an amount equal to the costs of detailing personnel and the fair market value of any supplies, equipment, or services provided by the Director. The Secretary shall, for the payment of expenses incurred in complying with such request, expend the amounts withheld.

`(d) APPLICABILITY OF CERTAIN PROVISIONS WITH RESPECT TO CONTRACTS- Contracts may be entered into under this part without regard to sections 3648 and 3709 of the Revised Statutes (31 U.S.C. 529 and 41 U.S.C. 5).

`SEC. 926. CERTAIN ADMINISTRATIVE AUTHORITIES.

`(a) DEPUTY DIRECTOR AND OTHER OFFICERS AND EMPLOYEES-

`(1) DEPUTY DIRECTOR- The Director may appoint a deputy director for the Agency.

`(2) OTHER OFFICERS AND EMPLOYEES- The Director may appoint and fix the compensation of such officers and employees as may be necessary to carry out this title. Except as otherwise provided by law, such officers and employees shall be appointed in accordance with the civil service laws and their compensation fixed in accordance with title 5, United States Code.

`(b) FACILITIES- The Secretary, in carrying out this title--

`(1) may acquire, without regard to the Act of March 3, 1877 (40 U.S.C. 34), by lease or otherwise through the Director of General Services, buildings or portions of buildings in the District of Columbia or communities located adjacent to the District of Columbia for use for a period not to exceed 10 years; and

`(2) may acquire, construct, improve, repair, operate, and maintain laboratory, research, and other necessary facilities and equipment, and such other real or personal property (including patents) as the Secretary deems necessary.

`(c) PROVISION OF FINANCIAL ASSISTANCE- The Director, in carrying out this title, may make grants to public and nonprofit entities and individuals, and may enter into cooperative agreements or contracts with public and private entities and individuals.

`(d) UTILIZATION OF CERTAIN PERSONNEL AND RESOURCES-

`(1) DEPARTMENT OF HEALTH AND HUMAN SERVICES- The Director, in carrying out this title, may utilize personnel and equipment, facilities, and other physical resources of the Department of Health and Human Services, permit appropriate (as determined by the Secretary) entities and individuals to utilize the physical resources of such Department, and provide technical assistance and advice.

`(2) OTHER AGENCIES- The Director, in carrying out this title, may use, with their consent, the services, equipment, personnel, information, and facilities of other Federal, State, or local public agencies, or of any foreign government, with or without reimbursement of such agencies.

`(e) CONSULTANTS- The Secretary, in carrying out this title, may secure, from time to time and for such periods as the Director deems advisable but in accordance with section 3109 of title 5, United States Code, the assistance and advice of consultants from the United States or abroad.

`(f) EXPERTS-

`(1) IN GENERAL- The Secretary may, in carrying out this title, obtain the services of not more than 50 experts or consultants who have appropriate scientific or professional qualifications. Such experts or consultants shall be obtained in accordance with section 3109 of title 5, United States Code, except that the limitation in such section on the duration of service shall not apply.

`(2) TRAVEL EXPENSES-

`(A) IN GENERAL- Experts and consultants whose services are obtained under paragraph (1) shall be paid or reimbursed for their expenses associated with traveling to and from their assignment location in accordance with sections 5724, 5724a(a), 5724a(c), and 5726(C) of title 5, United States Code.

`(B) LIMITATION- Expenses specified in subparagraph (A) may not be allowed in connection with the assignment of an expert or consultant whose services are obtained under paragraph (1) unless and until the expert agrees in writing to complete the entire period of assignment, or 1 year, whichever is shorter, unless separated or reassigned for reasons that are beyond the control of the expert or consultant and that are acceptable to the Secretary. If the expert or consultant violates the agreement, the money spent by the United States for the expenses specified in subparagraph (A) is recoverable from the expert or consultant as a statutory obligation owed to the United States. The Secretary may waive in whole or in part a right of recovery under this subparagraph.

`(g) VOLUNTARY AND UNCOMPENSATED SERVICES- The Director, in carrying out this title, may accept voluntary and uncompensated services.

`SEC. 927. FUNDING.

`(a) INTENT- To ensure that the United States investment in biomedical research is rapidly translated into improvements in the quality of patient care, there must be a corresponding investment in research on the most effective clinical and organizational strategies for use of these findings in daily practice. The authorization levels in subsections (b) and (c) provide for a proportionate increase in health care research as the United States investment in biomedical research increases.

`(b) AUTHORIZATION OF APPROPRIATIONS- For the purpose of carrying out this title, there are authorized to be appropriated $250,000,000 for fiscal year 2000, and such sums as may be necessary for each of the fiscal years 2001 through 2004.

`(c) EVALUATIONS- In addition to amounts available pursuant to subsection (b) for carrying out this title, there shall be made available for such purpose, from the amounts made available pursuant to section 241 (relating to evaluations), an amount equal to 40 percent of the maximum amount authorized in such section 241 to be made available for a fiscal year.

`SEC. 928. DEFINITIONS.

`In this title:

`(1) ADVISORY COUNCIL- The term `Advisory Council' means the National Advisory Council on Health Care Research and Quality established under section 921.

`(2) AGENCY- The term `Agency' means the Agency for Health Research and Quality.

`(3) DIRECTOR- The term `Director' means the Director of the Agency for Health Research and Quality.'.

(b) RULES OF CONSTRUCTION-

(1) IN GENERAL- Section 901(a) of the Public Health Service Act (as added by subsection (a) of this section) applies as a redesignation of the agency that carried out title IX of such Act on the day before the date of the enactment of this Act, and not as the termination of such agency and the establishment of a different agency. The amendment made by subsection (a) of this section does not affect appointments of the personnel of such agency who were employed at the agency on the day before such date.

(2) REFERENCES- Any reference in law to the Agency for Health Care Policy and Research is deemed to be a reference to the Agency for Health Research and Quality, and any reference in law to the Administrator for Health Care Policy and Research is deemed to be a reference to the Director of the Agency for Health Research and Quality.

SEC. 3. GRANTS REGARDING UTILIZATION OF PREVENTIVE HEALTH SERVICES.

Subpart I of part D of title III of the Public Health Service Act (42 U.S.C. 254b et seq.) is amended by adding at the end the following section:

`SEC. 330D. CENTERS FOR STRATEGIES ON FACILITATING UTILIZATION OF PREVENTIVE HEALTH SERVICES AMONG VARIOUS POPULATIONS.

`(a) IN GENERAL- The Secretary, acting through the appropriate agencies of the Public Health Service, shall make grants to public or nonprofit private entities for the establishment and operation of regional centers whose purpose is to identify particular populations of patients and facilitate the appropriate utilization of preventive health services by patients in the populations through developing and disseminating strategies to improve the methods used by public and private health care programs and providers in interacting with such patients.

`(b) RESEARCH AND TRAINING- The activities carried out by a center under subsection (a) may include establishing programs of research and training with respect to the purpose described in such subsection, including the development of curricula for training individuals in implementing the strategies developed under such subsection.

`(c) QUALITY MANAGEMENT- A condition for the receipt of a grant under subsection (a) is that the applicant involved agree that, in order to ensure that the strategies developed under such subsection take into account principles of quality management with respect to consumer satisfaction, the applicant will make arrangements with one or more private entities that have experience in applying such principles.

`(d) PRIORITY REGARDING INFANTS AND CHILDREN- In carrying out the purpose described in subsection (a), the Secretary shall give priority to various populations of infants, young children, and their mothers.

`(e) EVALUATIONS- The Secretary, acting through the appropriate agencies of the Public Health Service, shall (directly or through grants or contracts) provide for the evaluation of strategies under subsection (a) in order to determine the extent to which the strategies have been effective in facilitating the appropriate utilization of preventive health services in the populations with respect to which the strategies were developed.

`(f) AUTHORIZATION OF APPROPRIATIONS- For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2000 through 2004.'.

SEC. 4. PROGRAM OF PAYMENTS TO CHILDREN'S HOSPITALS THAT OPERATE GRADUATE MEDICAL EDUCATION PROGRAMS.

Part D of title III of the Public Health Service Act (42 U.S.C. 254b et seq.) is amended by adding at the end the following subpart:

`Subpart IX--Support of Graduate Medical Education Programs in Children's Hospitals

`SEC. 340E. PROGRAM OF PAYMENTS TO CHILDREN'S HOSPITALS THAT OPERATE GRADUATE MEDICAL EDUCATION PROGRAMS.

`(a) PAYMENTS- The Secretary shall make two payments under this section to each children's hospital for each of fiscal years 2000 and 2001, one for the direct expenses and the other for indirect expenses associated with operating approved graduate medical residency training programs.

`(b) AMOUNT OF PAYMENTS-

`(1) IN GENERAL- Subject to paragraph (2), the amounts payable under this section to a children's hospital for an approved graduate medical residency training program for a fiscal year are each of the following amounts:

`(A) DIRECT EXPENSE AMOUNT- The amount determined under subsection (c) for direct expenses associated with operating approved graduate medical residency training programs.

`(B) INDIRECT EXPENSE AMOUNT- The amount determined under subsection (d) for indirect expenses associated with the treatment of more severely ill patients and the additional costs relating to teaching residents in such programs.

`(2) CAPPED AMOUNT-

`(A) IN GENERAL- The total of the payments made to children's hospitals under paragraph (1)(A) or paragraph (1)(B) in a fiscal year shall not exceed the funds appropriated under paragraph (1) or (2), respectively, of subsection (f) for such payments for that fiscal year.

`(B) PRO RATA REDUCTIONS OF PAYMENTS FOR DIRECT EXPENSES- If the Secretary determines that the amount of funds appropriated under subsection (f)(1) for a fiscal year is insufficient to provide the total amount of payments otherwise due for such periods under paragraph (1)(A), the Secretary shall reduce the amounts so payable on a pro rata basis to reflect such shortfall.

`(c) AMOUNT OF PAYMENT FOR DIRECT GRADUATE MEDICAL EDUCATION-

`(1) IN GENERAL- The amount determined under this subsection for payments to a children's hospital for direct graduate expenses relating to approved graduate medical residency training programs for a fiscal year is equal to the product of--

`(A) the updated per resident amount for direct graduate medical education, as determined under paragraph (2); and

`(B) the average number of full-time equivalent residents in the hospital's graduate approved medical residency training programs (as determined under section 1886(h)(4) of the Social Security Act during the fiscal year.

`(2) UPDATED PER RESIDENT AMOUNT FOR DIRECT GRADUATE MEDICAL EDUCATION- The updated per resident amount for direct graduate medical education for a hospital for a fiscal year is an amount determined as follows:

`(A) DETERMINATION OF HOSPITAL SINGLE PER RESIDENT AMOUNT- The Secretary shall compute for each hospital operating an approved graduate medical education program (regardless of whether or not it is a children's hospital) a single per resident amount equal to the average (weighted by number of full-time equivalent residents) of the primary care per resident amount and the non-primary care per resident amount computed under section 1886(h)(2) of the Social Security Act for cost reporting periods ending during fiscal year 1997.

`(B) DETERMINATION OF WAGE AND NON-WAGE-RELATED PROPORTION OF THE SINGLE PER RESIDENT AMOUNT- The Secretary shall estimate the average proportion of the single per resident amounts computed under subparagraph (A) that is attributable to wages and wage-related costs.

`(C) STANDARDIZING PER RESIDENT AMOUNTS- The Secretary shall establish a standardized per resident amount for each such hospital--

`(i) by dividing the single per resident amount computed under subparagraph (A) into a wage-related portion and a non-wage-related portion by applying the proportion determined under subparagraph (B);

`(ii) by dividing the wage-related portion by the factor applied under section 1886(d)(3)(E) of the Social Security Act for discharges occurring during fiscal year 1999 for the hospital's area; and

`(iii) by adding the non-wage-related portion to the amount computed under clause (ii).

`(D) DETERMINATION OF NATIONAL AVERAGE- The Secretary shall compute a national average per resident amount equal to the average of the standardized per resident amounts computed under subparagraph (C) for such hospitals, with the amount for each hospital weighted by the average number of full-time equivalent residents at such hospital.

`(E) APPLICATION TO INDIVIDUAL HOSPITALS- The Secretary shall compute for each such hospital that is a children's hospital a per resident amount--

`(i) by dividing the national average per resident amount computed under subparagraph (D) into a wage-related portion and a non-wage-related portion by applying the proportion determined under subparagraph (B);

`(ii) by multiplying the wage-related portion by the factor described in subparagraph (C)(ii) for the hospital's area; and

`(iii) by adding the non-wage-related portion to the amount computed under clause (ii).

`(F) UPDATING RATE- The Secretary shall update such per resident amount for each such children's hospital by the estimated percentage increase in the consumer price index for all urban consumers during the period beginning October 1997 and ending with the midpoint of the hospital's cost reporting period that begins during fiscal year 2000.

`(d) AMOUNT OF PAYMENT FOR INDIRECT MEDICAL EDUCATION-

`(1) IN GENERAL- The amount determined under this subsection for payments to a children's hospital for indirect expenses associated with the treatment of more severely ill patients and the additional costs related to the teaching of residents for a fiscal year is equal to an amount determined appropriate by the Secretary.

`(2) FACTORS- In determining the amount under paragraph (1), the Secretary shall--

`(A) take into account variations in case mix among children's hospitals and the number of full-time equivalent residents in the hospitals' approved graduate medical residency training programs; and

`(B) assure that the aggregate of the payments for indirect expenses associated with the treatment of more severely ill patients and the additional costs related to the teaching of residents under this section in a fiscal year are equal to the amount appropriated for such expenses for the fiscal year involved under subsection (f)(2).

`(e) MAKING OF PAYMENTS-

`(1) INTERIM PAYMENTS- The Secretary shall determine, before the beginning of each fiscal year involved for which payments may be made for a hospital under this section, the amounts of the payments for direct graduate medical education and indirect medical education for such fiscal year and shall (subject to paragraph (2)) make the payments of such amounts in 26 equal interim installments during such period.

`(2) WITHHOLDING- The Secretary shall withhold up to 25 percent from each interim installment for direct graduate medical education paid under paragraph (1).

`(3) RECONCILIATION- At the end of each fiscal year for which payments may be made under this section, the hospital shall submit to the Secretary such information as the Secretary determines to be necessary to determine the percent (if any) of the total amount withheld under paragraph (2) that is due under this section for the hospital for the fiscal year. Based on such determination, the Secretary shall recoup any overpayments made, or pay any balance due. The amount so determined shall be considered a final intermediary determination for purposes of applying section 1878 of the Social Security Act and shall be subject to review under that section in the same manner as the amount of payment under section 1886(d) of such Act is subject to review under such section.

`(f) AUTHORIZATION OF APPROPRIATIONS-

`(1) DIRECT GRADUATE MEDICAL EDUCATION-

`(A) IN GENERAL- There are hereby authorized to be appropriated, out of any money in the Treasury not otherwise appropriated, for payments under subsection (b)(1)(A)--

`(i) for fiscal year 2000, $90,000,000; and

`(ii) for fiscal year 2001, $95,000,000.

`(B) CARRYOVER OF EXCESS- The amounts appropriated under subparagraph (A) for fiscal year 2000 shall remain available for obligation through the end of fiscal year 2001.

`(2) INDIRECT MEDICAL EDUCATION- There are hereby authorized to be appropriated, out of any money in the Treasury not otherwise appropriated, for payments under subsection (b)(1)(A)--

`(A) for fiscal year 2000, $190,000,000; and

`(B) for fiscal year 2001, $190,000,000.

`(g) DEFINITIONS- In this section:

`(1) APPROVED GRADUATE MEDICAL RESIDENCY TRAINING PROGRAM- The term `approved graduate medical residency training program' has the meaning given the term `approved medical residency training program' in section 1886(h)(5)(A) of the Social Security Act.

`(2) CHILDREN'S HOSPITAL- The term `children's hospital' means a hospital described in section 1886(d)(1)(B)(iii) of the Social Security Act.

`(3) DIRECT GRADUATE MEDICAL EDUCATION COSTS- The term `direct graduate medical education costs' has the meaning given such term in section 1886(h)(5)(C) of the Social Security Act.'.

SEC. 5. STUDY REGARDING SHORTAGES OF LICENSED PHARMACISTS.

(a) IN GENERAL- The Secretary of Health and Human Services (in this section referred to as the `Secretary'), acting through the appropriate agencies of the Public Health Services, shall conduct a study to determine whether and to what extent there is a shortage of licensed pharmacists. In carrying out the study, the Secretary shall seek the comments of appropriate public and private entities regarding any such shortage.

(b) REPORT TO CONGRESS- Not later than 1 year after the date of the enactment of this Act, the Secretary shall complete the study under subsection (a) and submit to the Congress a report that describes the findings made through the study and that contains a summary of the comments received by the Secretary pursuant to such subsection.

SEC. 6. REPORT ON TELEMEDICINE.

Not later than January 10, 2001, the Director of the Agency for Health Research and Quality shall submit to the Congress a report that--

(1) identifies any factors that inhibit the expansion and accessibility of telemedicine services, including factors relating to telemedicine networks;

(2) identifies any factors that, in addition to geographical isolation, should be used to determine which patients need or require access to telemedicine care;

(3) determines the extent to which--

(A) patients receiving telemedicine service have benefited from the services, and are satisfied with the treatment received pursuant to the services; and

(B) the medical outcomes for such patients would have differed if telemedicine services had not been available to the patients;

(4) determines the extent to which physicians involved with telemedicine services have been satisfied with the medical aspects of the services;

(5) determines the extent to which primary care physicians are enhancing their medical knowledge and experience through the interaction with specialists provided by telemedicine consultations; and

(6) identifies legal and medical issues relating to State licensing of health professionals that are presented by telemedicine services, and provides any recommendations of the Director for responding to such issues.

SEC. 7. BUY AMERICAN PROVISIONS.

(a) COMPLIANCE WITH BUY AMERICAN ACT- No funds authorized pursuant to this Act may be expended by an entity unless the entity agrees that in expending the assistance the entity will comply with sections 2 through 4 of the Act of March 3, 1933 (41 U.S.C. 10a-10c, popularly known as the `Buy American Act').

(b) SENSE OF THE CONGRESS; REQUIREMENT REGARDING NOTICE-

(1) PURCHASE OF AMERICAN-MADE EQUIPMENT AND PRODUCTS- In the case of any equipment or products that may be authorized to be purchased with financial assistance provided under this Act, it is the sense of the Congress that entities receiving such assistance should, in expending the assistance, purchase only American-made equipment and products.

(2) NOTICE TO RECIPIENTS OF ASSISTANCE- In providing financial assistance under this Act, the Secretary of Health and Human Services shall provide to each recipient of the assistance a notice describing the statement made in paragraph (1) by the Congress.

Passed the House of Representatives September 28, 1999.

Attest:

JEFF TRANDAHL,

Clerk.

END